ARL6IP4 antibody
Principal name
ARL6IP4 antibody
Alternative names for ARL6IP4 antibody
ARL-6-interacting protein 4, Aip-4, SR-15, SRp25, SR-25, HSP-975, HSVI-binding protein
Ncbi ID
9606, NP_001002251.1, NM_016638, NM_001002252, NP_653092.1, NM_018694, NM_001002251
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of ARL6IP4 antibody
- Kit Component:
- - KN301580G1, Arl6ip4 gRNA vector 1 in pCas-Guide vector
- KN301580G2, Arl6ip4 gRNA vector 2 in pCas-Guide vector
- KN301580D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
ARL6IP4 MaxPab rabbit polyclonal antibody. Western Blot analysis of ARL6IP4 expression in human liver.
Western Blot analysis of ARL6IP4 expression in transfected 293T cell line (H00051329-T02) by ARL6IP4 MaxPab polyclonal antibody.Lane 1: ARL6IP4 transfected lysate(38.40 KDa).Lane 2: Non-transfected lysate.
Immunoperoxidase of monoclonal antibody to ARL6IP4 on formalin-fixed paraffin-embedded human placenta. [antibody concentration 3 ug/ml]
Immunofluorescence of monoclonal antibody to ARL6IP4 on HeLa cell. [antibody concentration 10 ug/ml]
ARL6IP4 monoclonal antibody (M09), clone 5E5 Western Blot analysis of ARL6IP4 expression in Hela NE ( Cat # L013V3 ).
Host: Rabbit; Target Name: ARL6IP4; Sample Tissue: 721_B Whole Cell lysates; Antibody Dilution: 1.0ug/ml
WB Suggested Anti-ARL6IP4 Antibody; Titration: 1.0 ug/ml; Positive Control: Hela Whole cellARL6IP4 is supported by BioGPS gene expression data to be expressed in HeLa
Lysates
| Catalog No. | ||
|---|---|---|
| LY413884 | ARL6IP4 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY424188 | ARL6IP4 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
